CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The INTERCEPT-MDS project focuses on disease interception, aiming to identify and target altered cells before diseases develop. By training early-stage researchers, the project seeks to advance techniques in single-cell analysis and epigenetic regulation, particularly for myeloid diseases.
Disease interception is a novel concept referring to treatment of a disease before the disease fully develops by removing altered cells.
To make disease cell interception a reality we will need to overcome two key challenges.
First, we will need to be able to identify few altered disease cells among many healthy ones.
Second, we need to develop strategies that allow to specifically target disease cells but do not affect healthy cells.
In the INTERCEPT-MDS ITN we propose to approach these challen…
INSTITUT JOSEP CARRERAS - CERCA
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Frankfurt
Type: Research institute
Activity type: Research Organisations
SME: No
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Rotterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Munchen
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
